31140-7
LaboratorycefTRIAXone [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)
Definition
Susceptibility of an isolate to ceftriaxone in the context of a patient with meningitis, i.e., the "meningitis breakpoint". Various agencies, including the FDA and CLSI in the U.S. and EUCAST in Europe, publish guidelines for determining susceptibility of different organisms to different antimicrobials. In most cases, susceptibility does not vary by type of infection, but for a few specific types of infection, including meningitis, pneumonia and urinary tract infection, certain antimicrobials have different susceptibility thresholds.
LOINC 6-Axis Classification
Component
cefTRIAXone
Property
Susc
Time Aspect
Pt
System
Isolate.meningitis
Scale Type
OrdQn
Method Type
MIC
Details
Class
ABXBACT
Order/Observation
Observation
Short Name
cefTRIAXone Islt.mening MIC
Display Name
cefTRIAXone MIC (Isolate.meningitis) [Susc]
Related Names
Frequently Asked Questions
What is LOINC code 31140-7?
LOINC code 31140-7 identifies "cefTRIAXone [Susceptibility] for meningitis by Minimum inhibitory concentration (MIC)". Susceptibility of an isolate to ceftriaxone in the context of a patient with meningitis, i.e., the "meningitis breakpoint". Various agencies, including the FDA and CLSI in the U.S. and EUCAST in Europe, publish guidelines for determining susceptibility of different organisms to different antimicrobials. In most cases, susceptibility does not vary by type of infection, but for a few specific types of infection, including meningitis, pneumonia and urinary tract infection, certain antimicrobials have different susceptibility thresholds.
What does 31140-7 measure?
This code measures cefTRIAXone in Isolate.meningitis. It belongs to the ABXBACT class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.